Abstract
BackgroundIn advanced colorectal cancer (CRC), analysis of the tumor microenvironment (TME) may be useful as a predictive biomarker, particularly supporting the use of immunotherapies and anti-angiogenic therapies.1 The XernaTM TME...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have